author-photo

Herbert Kim Lyerly

Duke University

143

Papers

4043

Citations

Citation Trend

Filter By

Papers (101) Sort By

Journal Conference Others

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy.

2021 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS17-22: Intratumoral delivery of tavokinogene telseplasmid (plasmid IL-12) and electroporation induces an immune signature that predicts successful combination in patients

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Intratumoral plasmid IL-12 expands CD8+ T cells and induces a CXCR3 gene signature in triple-negative breast tumors that sensitizes patients to anti-PD-1 therapy.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Changes in peripheral blood regulatory T cells, and IL−6 and IL−10 levels predict response of pediatric medulloblastoma and germ cell tumors with residual or disseminated disease to craniospinal irradiation

2021 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
Infiltration of metastatic lymph nodes with PD-1+ T cells is associated with improved disease-free and overall survival in resected N+ NSCLC.

2020 American Journal of Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
An age-independent gene signature for monitoring acute rejection in kidney transplantation.

2020 Theranostics
Show All
- Source
- Cite
- Save
Citations (5)
DC-CIK as a widely applicable cancer immunotherapy

2020 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (6)
Clinical efficacy of intra-cavitary infusions of autologous dendritic cell/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and ascites

2020 American Journal of Translational Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PR2: Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo

2020
Show All
- Source
- Cite
- Save
Citations (0)
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (3)